Skip to content

Prone Position in Acute Bronchiolitis

Effect of Prone Position on the Use of Non-invasive and Invasive Ventilation in Infants With Moderate to Severe Acute Bronchiolitis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03976895
Acronym
PROPOSITIS
Enrollment
452
Registered
2019-06-06
Start date
2021-01-13
Completion date
2023-12-11
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Viral Bronchiolitis

Keywords

viral bronchiolitis, Prone position, high flow nasal cannula, noninvasive ventilation, Randomized controlled trial

Brief summary

Acute viral bronchiolitis is the leading cause of community-acquired acute respiratory failure in developed countries (20 000 to 30 000 hospitalizations each year in France). Between 5% and 22% of these children are hospitalized in a critical care unit to benefit from a respiratory support. Non-invasive ventilation, in particular the nasal Continuous Positive Airway Pressure (nCPAP), reduces the work of breathing in children with bronchiolitis and is associated with decreased morbidity and hospitalization costs compared with invasive ventilation. Nowadays, this technique is considered as the gold standard in the pediatric intensive care units (PICU) in France. High Flow Nasal Cannula (HFNC) has been proposed as an alternative to the nCPAP because of its better tolerance and simplicity of implementation. However, the proportion of failure remains high (35 to 50%), providing only a partial response to the care of these children, especially prior to the PICU. In a physiological study (NCT02602678, article published), it has been demonstrated that prone position (PP) decrease, by almost 50%, the respiratory work of breathing and improve the respiratory mechanics in infants hospitalized in intensive care units for bronchiolitis. Investigators hypothesize that prone position, during High Flow Nasal Cannula (HFNC), would significantly reduce the use of non-invasive ventilation (nCPAP and others) or invasive ventilation, as compared to supine position during HFNC, in infants with moderate to severe viral bronchiolitis.

Interventions

PROCEDURESupine position (SP)

Infants under high flow nasal cannula (HFNC) will be positioned in the supine position. Patients may be positioned temporarily in lateral position between periods of supine position to limit ventilatory disorders, as it is usually done in critical care units during bronchiolitis.

Infants under high flow nasal cannula (HFNC) will be placed in the prone position during at least 24 hours over the first 48 hours. The positioning will be standardized (chest on the bed plan and abdomen cleared) and children should be placed in the prone position immediately after randomization. Patients may be positioned temporarily in lateral position between periods of prone position to limit ventilatory disorders, as it is usually done in critical care units during bronchiolitis.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Months
Healthy volunteers
No

Inclusion criteria

* Infant under 6 months * Hospitalized in critical care unit (continuous monitoring unit or intensive care unit) * With a clinical diagnosis of acute viral bronchiolitis (criterion of the American Academy of Pediatrics 2014) * m-WCAS score ≥ 3 and / or hypercapnic acidosis with pH \<7.35 and pCO2\> 50mmHg (6.7 kPa) * Informed consent signed by at least one of the parents with oral consent of the other parent (and / or legal guardian) recorded in the medical file (with deferred written consent).

Exclusion criteria

* Infant admitted with criteria for invasive or non-invasive ventilation (hypercapnic acidosis with pH \<7.25 without ventilatory support and/or hypoxia with impossibility of maintaining SpO2\> 92% whatever the FiO2 and/or more than 3 significant apneas per hour and/or severe consciousness disorder) * Patient already positioned in the prone position before randomization for more than 3 hours * Significant comorbidities with a history of respiratory pathology (bronchodysplasia with ventilatory support), Ear Nose and Throat pathology (pharyngolaryngomalacia) or neuromuscular and / or hemodynamically significant congenital heart disease. * Contraindication to Prone position : recent abdominal surgery (laparoschisis or omphalocele) or recent sternotomy * Patient who is not affiliated (or does not benefit from) to a national social security system

Design outcomes

Primary

MeasureTime frameDescription
Proportion of ventilated children in each of the 2 groups3 daysIndications for the use of ventilation (invasive or non-invasive ventilation) will be standardized in both groups (based on the interregional protocol for the management of bronchiolitis): * Clinical aggravation defined by an increase ≥ 1 point of the m-WCAS score * Persistence of hypercapnic acidosis with pH ≤7.30 and pCO2≥ 8 kPa or FiO2\> 60% under HFNC at 2 L/kg/min * More than 3 significant apneas per hour (apnea with desaturation \<90% and / or bradycardia \<90 / min) * Consciousness disorder Anytime over the first 3 days after inclusion

Secondary

MeasureTime frameDescription
Proportion of failure3 daysFailure is defined as: * HFNC failure (composite failure criterion validated by an independent committee) * worsening of mWCAS score ≥ 1 point * hypercapnic acidosis (pH ≤7.30 and pCO2≥8kPa) * significant apnea (apnea with desaturation \<90% and / or bradycardia \<90/min) Anytime over the first 3 days after inclusion
Causes of failure3 daysFailure is defined as: * HFNC failure (composite failure criterion validated by an independent committee) * worsening of mWCAS score ≥ 1 point * hypercapnic acidosis (pH ≤7.30 and pCO2≥8kPa) * significant apnea (apnea with desaturation \<90% and / or bradycardia \<90/min) Anytime over the first 3 days after inclusion
Duration of ventilationmaximum 3 monthsDuration of ventilation (high flow nasal cannula, invasive, non-invasive) in hours. This data will be collected at critical care unit discharge.
Length of staymaximum 3 monthsLength of stay in days. This data will be collected at hospital discharge.
Oxygenation evaluation2 hoursEvolution of FiO2 and SpO2/FiO2 ratio between inclusion and H2.
Tolerance evaluationmaximum 3 monthsProportion of skin lesions, vomiting/regurgitation and exclusive enteral nutrition. This data will be collected at critical care unit discharge.
Variation EDIN score (Scale of pain and discomfort of the newborn) between inclusion and after 2 hours2 hoursScale ranges to 0 from 15 and is a combination of criteria: * Face: Relaxed=0 to Permanent tightness or prostrate face,frozen or purple face=3 * Body: Relaxed=0 to Permanent agitation,tightness of extremities and stiffness of limbs or very poor and limited motor skills with fixed body=3 * Sleep:Easily, extended and calm=0 to No sleep=3 * Relationship:Smile to the angels,smile answer,attentive to the listening=0 to Refuses contact,no relationship possible,howl or moan without any stimulation=3 * Comfort: Do not need comfort=0 to Inconsolable,desperate sucking=3
Evaluation of the feasibility of maintaining the position48 hoursProportion of children in the prone position repositioned definitively in the supine position before performing the cumulative 24 hours of prone position, cumulative hours of prone position in the first 48 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026